Skip to main content
Download PDF

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Molecular Neurodegeneration volume 15, Article number: 6 (2020) Cite this article

The Original Article was published on 08 November 2019

Correction to: Mol Neurodegener

https://doi.org/10.1186/s13024-019-0339-z

The original article [1] contains an error in the y-axes of Fig. 8’s sub-figures whereby ‘CSF’ is mistakenly mentioned instead of ‘serum’.

The correct version of Fig. 8 can be viewed ahead and should be considered in place of the original Fig. 8.

Fig. 8
figure 1

Significant reduction in GM1a and GD1a levels in serum from PD patients and significant reduction in all measured glycosphingolipids, except GlcCer, in serum from RBD patients. Levels of GlcCer (a), LacCer (b), Gb3 (c), Gb4 (d), GM3 (e), GM2 (f), GM1a (g) and GD1a (h) were determined in serum samples from control subjects (n = 15), PD patients (n = 30) and age-matched RBD patients (n = 30) with NP-HPLC (* = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001, one-way ANOVA). Data are presented as mean ± SD

Full size image

Reference

  1. Huebecker M, Moloney ER, van der Spoel AC, Priestman DA, Isacson O, Hallett PJ, Platt FM. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease. Mol Neurodegener. 2019;14:40 https://doi.org/10.1186/s13024-019-0339-z.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK

    Mylene Huebecker, David A. Priestman & Frances M. Platt

  2. Neuroregeneration Institute, McLean Hospital / Harvard Medical School, Belmont, MA, 02478, USA

    Elizabeth B. Moloney, Ole Isacson & Penelope J. Hallett

  3. Departments of Pediatrics and Biochemistry & Molecular Biology, Atlantic Research Centre, Dalhousie University, Halifax, NS, B3H 4R2, Canada

    Aarnoud C. van der Spoel

Authors
  1. Mylene Huebecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth B. Moloney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aarnoud C. van der Spoel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David A. Priestman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ole Isacson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Penelope J. Hallett
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Frances M. Platt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ole Isacson, Penelope J. Hallett or Frances M. Platt.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huebecker, M., Moloney, E.B., van der Spoel, A.C. et al. Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease. Mol Neurodegeneration 15, 6 (2020). https://doi.org/10.1186/s13024-019-0355-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13024-019-0355-z

Molecular Neurodegeneration

ISSN: 1750-1326